Literature DB >> 26483474

VEGF-B-Neuropilin-1 signaling is spatiotemporally indispensable for vascular and neuronal development in zebrafish.

Lasse D Jensen1, Masaki Nakamura2, Lars Bräutigam3, Xuri Li4, Yizhi Liu4, Nilesh J Samani5, Yihai Cao6.   

Abstract

Physiological functions of vascular endothelial growth factor (VEGF)-B remain an enigma, and deletion of the Vegfb gene in mice lacks an overt phenotype. Here we show that knockdown of Vegfba, but not Vegfbb, in zebrafish embryos by specific morpholinos produced a lethal phenotype owing to vascular and neuronal defects in the brain. Vegfba morpholinos also markedly prevented development of hyaloid vasculatures in the retina, but had little effects on peripheral vascular development. Consistent with phenotypic defects, Vegfba, but not Vegfaa, mRNA was primarily expressed in the brain of developing zebrafish embryos. Interestingly, in situ detection of Neuropilin1 (Nrp1) mRNA showed an overlapping expression pattern with Vegfba, and knockdown of Nrp1 produced a nearly identically lethal phenotype as Vegfba knockdown. Furthermore, zebrafish VEGF-Ba protein directly bound to NRP1. Importantly, gain-of-function by exogenous delivery of mRNAs coding for NRP1-binding ligands VEGF-B or VEGF-A to the zebrafish embryos rescued the lethal phenotype by normalizing vascular development. Similarly, exposure of zebrafish embryos to hypoxia also rescued the Vegfba morpholino-induced vascular defects in the brain by increasing VEGF-A expression. Independent evidence of VEGF-A gain-of-function was provided by using a functionally defective Vhl-mutant zebrafish strain, which again rescued the Vegfba morpholino-induced vascular defects. These findings show that VEGF-B is spatiotemporally required for vascular development in zebrafish embryos and that NRP1, but not VEGFR1, mediates the essential signaling.

Entities:  

Keywords:  Neuropilin; VEGF-B; brain development; vasculature; zebrafish

Mesh:

Substances:

Year:  2015        PMID: 26483474      PMCID: PMC4640767          DOI: 10.1073/pnas.1510245112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Hypoxia-induced retinopathy model in adult zebrafish.

Authors:  Ziquan Cao; Lasse D Jensen; Pegah Rouhi; Kayoko Hosaka; Toste Länne; John F Steffensen; Erik Wahlberg; Yihai Cao
Journal:  Nat Protoc       Date:  2010-11-04       Impact factor: 13.491

2.  Neuropilin is a receptor for the axonal chemorepellent Semaphorin III.

Authors:  Z He; M Tessier-Lavigne
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

3.  Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.

Authors:  S Soker; S Takashima; H Q Miao; G Neufeld; M Klagsbrun
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

4.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

6.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 8.  Vascular growth factors and lymphangiogenesis.

Authors:  Lotta Jussila; Kari Alitalo
Journal:  Physiol Rev       Date:  2002-07       Impact factor: 37.312

9.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Authors:  N Ferrara; K Carver-Moore; H Chen; M Dowd; L Lu; K S O'Shea; L Powell-Braxton; K J Hillan; M W Moore
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

View more
  17 in total

1.  De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism.

Authors:  Yanjie Fan; Wu Yin; Bing Hu; Antonie D Kline; Victor Wei Zhang; Desheng Liang; Yu Sun; Lili Wang; Sha Tang; Zöe Powis; Lei Li; Huifang Yan; Zhen Shi; Xiaoping Yang; Yinyin Chen; Jingmin Wang; Yuwu Jiang; Hu Tan; Xuefan Gu; Lingqian Wu; Yongguo Yu
Journal:  Am J Hum Genet       Date:  2018-08-16       Impact factor: 11.025

2.  Targeting circular RNA-MET for anti-angiogenesis treatment via inhibiting endothelial tip cell specialization.

Authors:  Mu-Di Yao; Qin Jiang; Yan Ma; Yan Zhu; Qiu-Yang Zhang; Ze-Hui Shi; Chen Zhao; Biao Yan
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 11.454

3.  Susceptibility to Cardiac Arrhythmias and Sympathetic Nerve Growth in VEGF-B Overexpressing Myocardium.

Authors:  Johanna Lähteenvuo; Olli-Pekka Hätinen; Antti Kuivanen; Jenni Huusko; Jussi Paananen; Markku Lähteenvuo; Jussi Nurro; Marja Hedman; Juha Hartikainen; Nihay Laham-Karam; Petri Mäkinen; Markus Räsänen; Kari Alitalo; Anthony Rosenzweig; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2020-03-19       Impact factor: 11.454

4.  Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy.

Authors:  Yin Zhang; Yunlong Yang; Kayoko Hosaka; Guichun Huang; Jingwu Zang; Fang Chen; Yun Zhang; Nilesh J Samani; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

Review 5.  Cerebrovascular development: mechanisms and experimental approaches.

Authors:  Timothy J A Chico; Elisabeth C Kugler
Journal:  Cell Mol Life Sci       Date:  2021-03-10       Impact factor: 9.261

6.  Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma.

Authors:  Xian Lin; Baocun Sun; Dongwang Zhu; Xiulan Zhao; Ran Sun; Yanhui Zhang; Danfang Zhang; Xueyi Dong; Qiang Gu; Yanlei Li; Fang Liu
Journal:  Cancer Sci       Date:  2016-06-28       Impact factor: 6.716

7.  Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice.

Authors:  Lianyue Ma; Mei Ni; Panpan Hao; Huixia Lu; Xiaoyan Yang; Xingli Xu; Cheng Zhang; Shanying Huang; Yuxia Zhao; Xiaoling Liu; Yun Zhang
Journal:  Oncotarget       Date:  2016-03-29

8.  Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism.

Authors:  Yunlong Yang; Yin Zhang; Hideki Iwamoto; Kayoko Hosaka; Takahiro Seki; Patrik Andersson; Sharon Lim; Carina Fischer; Masaki Nakamura; Mitsuhiko Abe; Renhai Cao; Peter Vilhelm Skov; Fang Chen; Xiaoyun Chen; Yongtian Lu; Guohui Nie; Yihai Cao
Journal:  Nat Commun       Date:  2016-09-01       Impact factor: 14.919

9.  Vegfaa instructs cardiac muscle hyperplasia in adult zebrafish.

Authors:  Ravi Karra; Matthew J Foglia; Wen-Yee Choi; Christine Belliveau; Paige DeBenedittis; Kenneth D Poss
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 12.779

10.  Co-option of pre-existing vascular beds in adipose tissue controls tumor growth rates and angiogenesis.

Authors:  Sharon Lim; Kayoko Hosaka; Masaki Nakamura; Yihai Cao
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.